ASH 2018 | Mohamad Mohty’s myeloma highlights from ASH 2018
Mohamad Mohty, MD, PhD, of the University Pierre & Marie Curie, Paris, France, shares his highlights for multiple myeloma (MM) from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA. Prof. Mohty discusses advancements offering a promising outlook for MM patients, including BiTEs, CAR T-cell therapies, and daratumumab.
